Baptist Health Cancer Care | Association Partnerships

About Baptist Health Cancer Care

Baptist Health Cancer Care is the largest cancer program in South Florida, providing local, out-of-state and international patients with the most advanced cancer care. With locations from the Florida Keys to the Palm Beaches, the program provides cancer patients access to a full array of innovative clinical trials, physicians dedicated to bringing discovery to the bedside, access to personalized cancer treatments and comprehensive patient support services -- all delivered with unparalleled compassion. Baptist Health Cancer Care includes its state-of-the-art premier institutes, Baptist Health Miami Cancer Institute and Baptist Health Lynn Cancer Institute, with renowned subspecialized surgical oncologists, medical oncologists and radiation oncologists, and highly advanced technologies available to treat every common and rare cancer.

Baptist Health Cancer Care is part of Baptist Health, based in South Florida, providing care through a network of 12 hospitals as well as more than 150 outpatient facilities and physician practices, welcoming more than 1.5 million patients from around the world each year. Baptist Health Cancer Care is also Florida’s only member of the Memorial Sloan Kettering Cancer Alliance, an alliance based on common standards of care and many shared clinical trials.

To learn more about Baptist Health Cancer Care, visit baptisthealth.net/cancercare.

Connect with us:

Latest from Baptist Health Cancer Care


Perez on Real-World Pola-BR Treatment Outcomes in Patients with R/R LBCL

January 16, 2023

In an interview with Targeted Oncology, Ariel Perez, MD, explained the outcomes of patients with R/R large B-cell lymphoma who were treated with Pola-BR in the real-world setting, and the key takeaways from a single-institution study.

Preventing and Managing Cytomegalovirus After Hematopoietic Stem Cell Transplant

January 14, 2023

In an interview with Targeted Oncology, Guenther Koehne, MD, PhD provided a detailed explanation on the impact of cytomegalovirus reactivation post-transplant, cytomegalovirus reactivation prevention, and refractory cytomegalovirus reactivation.

Utilizing Big Data to Understand Disparities in Cancer Care Across South Florida

June 23, 2022

In an interview with Targeted Oncology, Leonard A. Kalman, MD, discussed how real-world data will improve the understanding of patients with cancer being treated at Miami Cancer Institute and of how the business runs overall.